Single-use Bioprocessing Material
Market was valued at $2,800.0 million in 2016, and is projected to
reach $9,342.1 million by 2023, growing at a CAGR of 18.7% from 2017 to 2023.
The plastic segment accounted for five-eighths share of the global market in
2016.
Single-use bioprocessing technology has gained
significant traction in the recent years, owing to the rapid adoption of
disposable bioprocessing equipment by pharmaceutical manufacturers. This has
fueled the manufacturers to integrate different materials in the construction
of single-use bioprocessing products. These products have also proved
beneficial for the small scale pharmaceutical manufacturers. Hence, most
biopharmaceutical companies utilize single-use bioprocessing technology for
manufacturing vaccines, monoclonal antibodies, and other pharmaceutical
components on commercial scale. This has spurred the demand for high-grade
plastic and silicone materials in the development of SUB products.
Download PDF Report Sample with statistical info
@ https://www.alliedmarketresearch.com/request-sample/4600
The polyethylene segment is the major
contributor to the revenue generated by the plastic segment is 2016 and is
anticipated to maintain this dominance throughout the forecast period. Variants
of polyethylene, such as high-density polyethylene (HDPE), low-density
polyethylene (LDPE), and medium-density polyethylene (MDPE) are used to
manufacture single-use bioprocessing products. In addition, polyethylene is
extensively used in the construction of media bags along with the films used in
the bioprocess containers.
Moreover, biopharmaceutical manufacturers
segment has dominated the global market in 2016 and is anticipated to maintain
this trend throughout the forecast period. The major driving force of the
increasing utilization of single-use bioprocessing systems is the collaboration
between leading manufacturers and small-scale suppliers of filtration,
container or closure systems, mixing systems, fermentation systems, and cell
culture systems (bioreactors).
Key Findings of the Single-use Bioprocessing
Material Market:
- The silicone material segment accounted for
second largest share in the global market in 2016 and is expected to
maintain this trend throughout the forecast period.
- Other plastic material segment is
anticipated to grow at the fastest pace from 2017-2023.
- Contract research organization &
manufacturers registered highest growth in the global single-use
bioprocessing material market during the forecast period.
- North America dominated the single-use
bioprocessing material market in 2016 and is anticipated to maintain this
trend throughout the forecast period.
- UK is anticipated to grow at the fastest
pace in the European single-use bioprocessing market during the forecast
period.
Asia-Pacific witnessed highest growth rate for
single-use bioprocessing market and is expected to continue this trend
throughout the forecast period. This is attributed to the rise in expenditure
on healthcare along with the improvement in medical and healthcare
infrastructure. In addition, the key market players focus on the opportunities
offered by the growing demand for single-use bioprocess systems. Such systems
are highly cost-effective, which has gained popularity among end users in this
region. Moreover, significant growth of pharmaceutical and the biotechnology
industries across the countries of Asia-Pacific region have supplemented the
market growth.
The major companies profiled in the report
include Thermo Fisher Scientific, Danaher Corporation, GE Healthcare (General
Electric Company), Sartorius Stedim Biotech S.A, Merck Millipore (Merck Group),
3M Company, Eppendorf AG, Finesse Solutions, Inc., Applikon Biotechnology B.V.,
and Cesco Bioengineering Co., Ltd. The other companies profiled in this report
include Octane Biotech Inc., PBS Biotech, Inc., Meissner Filtration Products,
Inc., Sentinel Process Systems Inc., CMC Biologics (Asahi Glass Co.), Novasep,
PendoTECH, and BioPure Technology Ltd.
No comments:
Post a Comment